Clinical Trial Update: Sero-conversion Study for a Two-dose Schedule of Sabin IPV in China [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on a two-dose Sabin IPV schedule conducted in China; completed study evaluating seroconversion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Sabin inactivated poliovirus vaccine (IPV) two-dose schedule (inactivated poliovirus vaccine)

Snippet

Sponsor: Centers for Disease Control and Prevention, China | Conditions: Poliomyelitis | Phase 4 | Status: COMPLETED